Cargando…

Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study

BACKGROUND: Hepatitis C virus is the leading cause of liver cirrhosis and hepatocellular carcinoma in Japan. We aimed to examine the long-term (> 20 years) mortality and hepatocellular carcinoma rates and associated risk factors in 1412 Japanese patients with decompensated hepatitis C virus-relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiyama, Shunichiro, Akuta, Norio, Sezaki, Hitomi, Kobayashi, Mariko, Kawamura, Yusuke, Hosaka, Tetsuya, Kobayashi, Masahiro, Saitoh, Satoshi, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Arase, Yasuji, Ikeda, Kenji, Kumada, Hiromitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066946/
https://www.ncbi.nlm.nih.gov/pubmed/33892649
http://dx.doi.org/10.1186/s12876-021-01770-0
_version_ 1783682686753177600
author Fujiyama, Shunichiro
Akuta, Norio
Sezaki, Hitomi
Kobayashi, Mariko
Kawamura, Yusuke
Hosaka, Tetsuya
Kobayashi, Masahiro
Saitoh, Satoshi
Suzuki, Fumitaka
Suzuki, Yoshiyuki
Arase, Yasuji
Ikeda, Kenji
Kumada, Hiromitsu
author_facet Fujiyama, Shunichiro
Akuta, Norio
Sezaki, Hitomi
Kobayashi, Mariko
Kawamura, Yusuke
Hosaka, Tetsuya
Kobayashi, Masahiro
Saitoh, Satoshi
Suzuki, Fumitaka
Suzuki, Yoshiyuki
Arase, Yasuji
Ikeda, Kenji
Kumada, Hiromitsu
author_sort Fujiyama, Shunichiro
collection PubMed
description BACKGROUND: Hepatitis C virus is the leading cause of liver cirrhosis and hepatocellular carcinoma in Japan. We aimed to examine the long-term (> 20 years) mortality and hepatocellular carcinoma rates and associated risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis (Child–Pugh B or C). METHODS: Cumulative survival and hepatocellular carcinoma rates were determined using Kaplan–Meier analysis. Independent risk factors were identified by multivariate analysis. A two-tailed P-value of < 0.05 was considered significant. RESULTS: The patients were followed up for a median of 2 years (range 0.5–24.2 years). In total, 62.3%, 41.7%, 4.7%, and 68.3% of the patients had a history of hepatocellular carcinoma, ascites, hepatic encephalopathy, and esophageal varices, respectively. The 1-, 5-, 10-, and 20-year cumulative overall survival rates in the total cohort was 74.9%, 29.0%, 9.1%, and 1.4%, respectively. The 1-, 3-, 5-, and 10-year cumulative survival rates for patients without hepatocellular carcinoma were 93.1%, 54.4%, 18.2%, and 4.0%, respectively, and the corresponding cumulative post-decompensation hepatocellular carcinoma rates were 14.0%, 31.6%, 46.1%, and 66.2%, respectively. The independent risk factors for mortality were older age, Child–Pugh C cirrhosis, the presence of hepatocellular carcinoma, low estimated glomerular filtration rate, low serum sodium level, low platelet count, and high γ-glutamyl transferase and α-fetoprotein levels for all patients and older age, Child–Pugh C cirrhosis, and low estimated glomerular filtration rate for patients without hepatocellular carcinoma. Overall, 1035 patients (73.3%) died; the causes of death were liver failure with/without hepatocellular carcinoma, pneumonia, sepsis, cardiovascular disease, and non-hepatocellular carcinoma malignancies. The corresponding morality rates per person-year were 133.4, 59.9, 10.9, 10.6, 9.0, and 5.2, respectively. CONCLUSIONS: Among Japanese patients with decompensated hepatitis C virus-related cirrhosis, hepatocellular carcinoma is associated with poor prognosis. Our results highlight the importance of managing liver-related events, including hepatocellular carcinoma, in these patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-021-01770-0.
format Online
Article
Text
id pubmed-8066946
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80669462021-04-26 Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study Fujiyama, Shunichiro Akuta, Norio Sezaki, Hitomi Kobayashi, Mariko Kawamura, Yusuke Hosaka, Tetsuya Kobayashi, Masahiro Saitoh, Satoshi Suzuki, Fumitaka Suzuki, Yoshiyuki Arase, Yasuji Ikeda, Kenji Kumada, Hiromitsu BMC Gastroenterol Research BACKGROUND: Hepatitis C virus is the leading cause of liver cirrhosis and hepatocellular carcinoma in Japan. We aimed to examine the long-term (> 20 years) mortality and hepatocellular carcinoma rates and associated risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis (Child–Pugh B or C). METHODS: Cumulative survival and hepatocellular carcinoma rates were determined using Kaplan–Meier analysis. Independent risk factors were identified by multivariate analysis. A two-tailed P-value of < 0.05 was considered significant. RESULTS: The patients were followed up for a median of 2 years (range 0.5–24.2 years). In total, 62.3%, 41.7%, 4.7%, and 68.3% of the patients had a history of hepatocellular carcinoma, ascites, hepatic encephalopathy, and esophageal varices, respectively. The 1-, 5-, 10-, and 20-year cumulative overall survival rates in the total cohort was 74.9%, 29.0%, 9.1%, and 1.4%, respectively. The 1-, 3-, 5-, and 10-year cumulative survival rates for patients without hepatocellular carcinoma were 93.1%, 54.4%, 18.2%, and 4.0%, respectively, and the corresponding cumulative post-decompensation hepatocellular carcinoma rates were 14.0%, 31.6%, 46.1%, and 66.2%, respectively. The independent risk factors for mortality were older age, Child–Pugh C cirrhosis, the presence of hepatocellular carcinoma, low estimated glomerular filtration rate, low serum sodium level, low platelet count, and high γ-glutamyl transferase and α-fetoprotein levels for all patients and older age, Child–Pugh C cirrhosis, and low estimated glomerular filtration rate for patients without hepatocellular carcinoma. Overall, 1035 patients (73.3%) died; the causes of death were liver failure with/without hepatocellular carcinoma, pneumonia, sepsis, cardiovascular disease, and non-hepatocellular carcinoma malignancies. The corresponding morality rates per person-year were 133.4, 59.9, 10.9, 10.6, 9.0, and 5.2, respectively. CONCLUSIONS: Among Japanese patients with decompensated hepatitis C virus-related cirrhosis, hepatocellular carcinoma is associated with poor prognosis. Our results highlight the importance of managing liver-related events, including hepatocellular carcinoma, in these patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-021-01770-0. BioMed Central 2021-04-23 /pmc/articles/PMC8066946/ /pubmed/33892649 http://dx.doi.org/10.1186/s12876-021-01770-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fujiyama, Shunichiro
Akuta, Norio
Sezaki, Hitomi
Kobayashi, Mariko
Kawamura, Yusuke
Hosaka, Tetsuya
Kobayashi, Masahiro
Saitoh, Satoshi
Suzuki, Fumitaka
Suzuki, Yoshiyuki
Arase, Yasuji
Ikeda, Kenji
Kumada, Hiromitsu
Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study
title Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study
title_full Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study
title_fullStr Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study
title_full_unstemmed Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study
title_short Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study
title_sort mortality rates and risk factors in 1412 japanese patients with decompensated hepatitis c virus-related cirrhosis: a retrospective long-term cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066946/
https://www.ncbi.nlm.nih.gov/pubmed/33892649
http://dx.doi.org/10.1186/s12876-021-01770-0
work_keys_str_mv AT fujiyamashunichiro mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy
AT akutanorio mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy
AT sezakihitomi mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy
AT kobayashimariko mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy
AT kawamurayusuke mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy
AT hosakatetsuya mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy
AT kobayashimasahiro mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy
AT saitohsatoshi mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy
AT suzukifumitaka mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy
AT suzukiyoshiyuki mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy
AT araseyasuji mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy
AT ikedakenji mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy
AT kumadahiromitsu mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy